146 related articles for article (PubMed ID: 446131)
1. Short-course chemotherapy of tuberculosis with largely twice-weekly isoniazid-rifampin.
Dutt AK; Jones L; Stead WW
Chest; 1979 Apr; 75(4):441-7. PubMed ID: 446131
[TBL] [Abstract][Full Text] [Related]
2. Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.
Dutt AK; Moers D; Stead WW
Am J Med; 1984 Aug; 77(2):233-42. PubMed ID: 6431810
[TBL] [Abstract][Full Text] [Related]
3. Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis.
Dutt AK; Moers D; Stead WW
Am Rev Respir Dis; 1983 Sep; 128(3):419-24. PubMed ID: 6614636
[TBL] [Abstract][Full Text] [Related]
4. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Long MW; Snider DE; Farer LS
Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
[TBL] [Abstract][Full Text] [Related]
5. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis.
Castelo A; Jardim JR; Goihman S; Kalckman AS; Dalboni MA; da Silva EA; Haynes RB
Lancet; 1989 Nov; 2(8673):1173-6. PubMed ID: 2572899
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
[TBL] [Abstract][Full Text] [Related]
7. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
Dutt AK; Moers D; Stead WW
Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
[TBL] [Abstract][Full Text] [Related]
8. Short-course chemotherapy for tuberculosis in children.
Abernathy RS; Dutt AK; Stead WW; Moers DJ
Pediatrics; 1983 Dec; 72(6):801-6. PubMed ID: 6606156
[TBL] [Abstract][Full Text] [Related]
9. A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
Constans P; Baron A; Parrot R; Coury C
Chest; 1972 Jun; 61(6):539-49. PubMed ID: 4624276
[No Abstract] [Full Text] [Related]
10. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
11. Rifampin.
Schonell M; Dorken E; Grzybowski S
Can Med Assoc J; 1972 Apr; 106(7):783-6. PubMed ID: 4622757
[TBL] [Abstract][Full Text] [Related]
12. Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.
Reis FJ; Bedran MB; Moura JA; Assis I; Rodrigues ME
Am Rev Respir Dis; 1990 Nov; 142(5):996-9. PubMed ID: 2240853
[TBL] [Abstract][Full Text] [Related]
13. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
[No Abstract] [Full Text] [Related]
14. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
15. Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian plains Aborigines.
McNab BD; Marciniuk DD; Alvi RA; Tan L; Hoeppner VH
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):989-93. PubMed ID: 10988118
[TBL] [Abstract][Full Text] [Related]
16. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.
Am Rev Respir Dis; 1977 Nov; 116(5):807-20. PubMed ID: 411405
[No Abstract] [Full Text] [Related]
17. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
Favez G; Chioléro R; Willa C
Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
[No Abstract] [Full Text] [Related]
18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
[No Abstract] [Full Text] [Related]
20. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
Zierski M
Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
